Drugs / Tradjenta
Regulatory milestones approvals, filings & regulatory actions · 7 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (6) | US (FDA) | TRADJENTA | — | 2012-05-22 – 2023-06-20 | fda.gov ↗ |
| Approved | US (FDA) | TRADJENTA | — | 2011-05-02 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03766750 Comparator | Dec 2021 → Oct 2023 | type 2 diabetes mellitus | EMS | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tradjenta | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03766750 ↗ |